Boceprevir Impurity 8 CAS CATO-C4X-25258
| CAS No. | CATO-C4X-25258 |
| Molecular Formula | C23H33F3N4O6 |
| Molecular Weight | 518.53 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Boceprevir Impurity 8.
As a process- or degradation-related impurity, Boceprevir Impurity 8 (CAS CATO-C4X-25258, C23H33F3N4O6) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Owing to a flavonoid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution, Boceprevir Impurity 8 is typically pale yellow to yellow crystalline powder. Its solid-state physicochemical attributes — including a molecular weight of 518.53 g/mol — guide the selection of appropriate sample preparation and analytical techniques. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Boceprevir Impurity 8 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C23H33F3N4O6 |
| Molecular Weight | 518.53 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | >95% |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 8.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F-containing |
| Nitrogen Atoms | 4 |
Related Boceprevir Standards
- Boceprevir Impurity 7 (CAS CATO-C4X-25257)
- Boceprevir Impurity 9 (CAS CATO-C4X-25259)
- Boceprevir-d9 (CAS 1256751-11-7)
- Boceprevir (CAS 394730-60-0)
- Boceprevir Impurity 5 (CAS CATO-C4X-25255)
- Boceprevir Impurity 13 (CAS CATO-C4X-252513)
- Boceprevir Impurity 4 (CAS CATO-C4X-25254)
- Boceprevir Impurity 6 (CAS CATO-C4X-25256)
Recommended Standards
- Apalutamide Impurity 96 (CAS CATO-C4X-274996)
- Relugolix Impurity 32 (CAS CATO-C4X-242932)
- 1-(4-(8-Amino-3-(tert-butyl)imidazo[1,5-a]pyrazin-1-yl)naphthalen-1-yl)-3-(3-(trifluoromethyl)phenyl)urea (CAS 1589527-65-0)
- Ponatinib Impurity 54 (CAS CATO-C4X-226954)
- Exemestane EP Impurity B (CAS 184972-09-6)
- Evocalcet Impurity 13 (CAS CATO-C4X-248513)
- Levothyroxine (CAS CATO-C4X-167855)
- 2-chloromethanesulfonylpropane (CAS 795307-01-6)
- N1-cyclohexyl-N2-(3,4-dichlorophenyl)oxalamide (CAS 329078-61-7)
- [Tyr38, Phe42,46] Bone Gla Protein (CAS 129356-77-0)
- 3-Methyl-1-(2-(phenylthio)ethyl)-1H-pyrazol-5(4H)-one (CAS 55294-10-5)
- Tofacitinib Impurity 134 (CAS CATO-C4X-1079134)
- Menaquinone 13 (CAS 27123-36-0)
- Liraglutide Impurity 16 TFA Salt (CAS CATO-C4X-199216)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com